Skip to main content
SpringerLink
Log in

Future Prospects for Drug Design of Lymphocyte Modulators

  • Chapter
The Pharmacology of Lymphocytes

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 85))

Abstract

There are well-established procedures for the design and presentation of scientific reviews. Unfortunately, all of the conventions and rules developed in this context are quite useless when it comes to writing a scientific preview, or to put it more bluntly, to predicting the future of a given area of research. By its very nature, scientific progress is unpredictable. We are entitled to assume that progress will continue in the future as it has in the past, but we know nothing about its quality, and we can only guess at which point in time a particular scientific question can be answered. The task of designing future therapy in any area of pharmacology is therefore a rather futile one, and is more likely to contribute to the amusement of future generations of scientists than to the enlightenment of the present one. However, drug therapy is not only a matter of research, but also a matter of applying the results of basic research to a particular therapeutic purpose, a process which we may call development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adelman NE, Watling DL, McDevitt HO (1983) Treatment of (NZB x NZW) F1 disease with anti-IA monoclonal antibodies. J Exp Med 158: 1350–1355

    Article  PubMed  CAS  Google Scholar 

  • Allum WH, Macdonald F, Fielding JW (1986) Monoclonal antibodies in the diagnosis and treatment of malignant conditions. Surg Annu 18:41–64

    PubMed  CAS  Google Scholar 

  • Atkins MB, Gould JA, Allegretta M, Li JJ, Dempsey RA, Rudders RA, Parkinson DR, Reichlin S, Mier JW (1986) Phase I evaluation of a recombinant interleukin-2 in patients with advanced malignant disease. J Clin Oncol 4:1380–1391

    PubMed  CAS  Google Scholar 

  • Avella J, Binder HJ, Madsen JE, Askenase PhW (1978) Effect of histamine H2receptor antagonists on delayed hypersensitivity. Lancet 1:624–626

    Article  PubMed  CAS  Google Scholar 

  • Baldwin RW, Byers VS (1985) Monoclonal antibodies for cancer detection and therapy. Academic, London

    Google Scholar 

  • Basciano L-AK, Berenstein EH, Kmak L, Siraganian RP (1986) Monoclonal antibodies that inhibit IgE binding. J Biol Chem 261:11823–11831

    PubMed  CAS  Google Scholar 

  • Benjamin RJ, Waldmann H (1986) Induction of tolerance by monoclonal antibody therapy. Nature 320:449–451

    Article  PubMed  CAS  Google Scholar 

  • Benjamin RH, Cobbolt SP, Clark MR, Waldmann H (1986) Tolerance to rat monoclonal antibodies. Implications for serotherapy. J Exp Med 163:1539–1552

    Article  PubMed  CAS  Google Scholar 

  • Bennett J, Zloty P, McKneally M (1982) Cimetidine blocks the development of tumor-induced suppressor T-cell activity. Int J Immunopharmacol 4:280

    Article  Google Scholar 

  • Berridge MJ, Irvine RF (1984) Inositol triphosphate, a novel second messenger in cellular signal-transduction. Nature 312:315–321

    Article  PubMed  CAS  Google Scholar 

  • Biddison WE, Rao PE, Talle MA, Goldstein G, Shaw S (1984) Possible involvement of the T4 molecules in T cell recognition of class II HLA antigens: evidence from studies of CTL-target cell binding. J Exp Med 159:783–797

    Article  PubMed  CAS  Google Scholar 

  • Bijsterbosch MK, Meade ChJ, Turner GA, Klaus GGB (1985) B lymphocyte receptors and polyphosphoinositide degradation. Cell 41:999–1006

    Article  PubMed  CAS  Google Scholar 

  • Blackwell GJ, Carnuccio R, DiRosa M, Flower RJ, Parente L, Persico P (1980) Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287:147–149

    Article  PubMed  CAS  Google Scholar 

  • Boitard C, Mishic S, Serrurier P, Butcher GW, Larkins AP, McDevitt HO (1985) In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility gene products. Proc Natl Acad Sci USA 82:6627–6632

    Article  PubMed  CAS  Google Scholar 

  • Borst J, Alexander S, Elder J, Terhorst C (1983) The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. J Biol Chem 258:5135–5141

    PubMed  CAS  Google Scholar 

  • Borst J, Coligan JE, Oettgen H, Pessano S, Malin R, Terhorst C (1984) The S and s-chains of the human T3/T-cell receptor complex are distinct polypeptides. Nature 312:455–458

    Article  PubMed  CAS  Google Scholar 

  • Bortin MM (1986) Allogeneic bone marrow transplantation in leukemia patients. Curr Probt Cancer 10:1–52

    Article  CAS  Google Scholar 

  • Brenner MB, McLean J, Dialynas DP, et al. (1986) Identification of a putative second T cell receptor. Nature 322:145–149

    Article  PubMed  CAS  Google Scholar 

  • Brostoff SW, Mason DW (1984) Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J Immunol 133:1938–1943

    PubMed  CAS  Google Scholar 

  • Cahill J, Hopper KE (1984) Immunoregutation by macrophages III. Prostaglandin E suppresses lymphocyte activation but not macrophage effector function during Salmonella enteritidis infection. Int J Immunopharmacol 6:9–17

    Article  PubMed  CAS  Google Scholar 

  • Cambier JC, Monroe JG, Coggeshali KM, et al. (1985) The biochemical basis of transmembrane signalling by B lymphocyte surface immunoglobulin. Immunol Today 6:218–222

    Article  CAS  Google Scholar 

  • Cantrell MA, Anderson D, Cerretti DP, et al. (1985) Cloning sequence and expression of a human granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci USA 82:6250–6254

    Article  PubMed  CAS  Google Scholar 

  • Chatenoud L, Baudrihaye MF, Kreis H, Goldstein G, Bach JF (1985) The restricted immune response to the murine monoclonal OKT3 antibody. Transplant Proc 17:558–559

    Google Scholar 

  • Chatenoud L, Jonker M, Villemain G, Goldstein G, Bach JF (1986) The human immune response to the OKT3 monoclonal antibody is oligoclonal. Science 232:1406–1408

    Article  PubMed  CAS  Google Scholar 

  • Chedid LA, Parant MA, Audibert FM, Riveau GJ, Parant FJ, Lederer E, Choay JP, Lefrancier PL (1982) Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infect Immun 35:417–424

    PubMed  CAS  Google Scholar 

  • Cheever MA, Greenberg PD, Fefer A (1984) Potential for specific cancer therapy with immune T lymphocytes. J Biol Response Mod 3:113–127

    PubMed  CAS  Google Scholar 

  • Chiao JW, Heil M, Arlin Z, Lutton JD, Choi JS, Leung K (1986) Suppression of lymphocyte activation and functions by a leukemia cell-derived inhibitor. Proc Natl Acad Sci USA 83:3432–3436

    Article  PubMed  CAS  Google Scholar 

  • Clark EA, Ledbetter JA (1986) Amplification of the immune response by agonistic antibodies. Immunol Today 7:267–270

    Article  CAS  Google Scholar 

  • Cloix JF, Colard O, Rothut B, Russo-Marie F (1983) Characterization and partial purification of “renocortins”: two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids. Br J Pharmacol 79:313–321

    PubMed  CAS  Google Scholar 

  • Cobbolt SP, Martin G, Ain S, Waldmann H (1986) Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323:164–166

    Article  Google Scholar 

  • Cohen FE, Kosen PA, Kuntz ID, Eppstein LB, Ciardelli TL, Smith KA (1986) Structure-activity studies of interleukin-2. Science 234:349–352

    Article  PubMed  CAS  Google Scholar 

  • De Simone C, Meli D, Sbricoli M, Rebuzzi E, Koverech A (1982) In vitro effect of inosiplex on T lymphocytes. J Immunopharmacol 4:139–152

    PubMed  Google Scholar 

  • Dembic Z, Haas W, Weiss S, McCurbey J, Kiefer H, Boehmer H, Steinmetz M (1986) Transfer of specificity by murine a and ß T cell receptor genes. Nature 320:232–238

    Article  PubMed  CAS  Google Scholar 

  • Dijk H van, Rademaker PM, Kerkhofs JP, Willers JMN (1980) Histamine 2-receptor-mediated immunomodulation in the mouse. II. Immunomodulation by the H2 antagonist metiamide. Int J Immunopharmacol 2:345–352

    Article  PubMed  Google Scholar 

  • Dinarello CA (1986) Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin). In: Cruse M, Lewis RE (eds) The Year in Immunology, vol 2. Karger, Basel, pp 68–89

    Google Scholar 

  • Donahue RE, Wang EA, Stone DK, Kamen R, Wong GG, Sehgal PK, Nathan DG, Clark SC (1986) Stimulation of hematopoiesis in primates by continuous infusion of recombinant human GM-CFS. Nature 321:872–875

    Article  PubMed  CAS  Google Scholar 

  • Drews J (1984) The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. Infection 13:241–250

    Article  Google Scholar 

  • Drews J (1986) Immunpharmakologie, Grundlagen, Perspektiven. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Duff G (1985) Many roles for interleukin-1. Nature 313:352–353

    Article  PubMed  CAS  Google Scholar 

  • Duff GW, Durum SK (1983) The pyrogenic and mitogenic actions of interleukin-1 are related. Nature 304:449–451

    Article  PubMed  CAS  Google Scholar 

  • Ferrara JLM, Marion A, McIntyre JF, Murphy GF, Burakoff SJ (1986) Amelioration of acute graft versus host disease due to minor histocompatibility antigens by in vivo administration of anti-interleukin-2 receptor antibody. J Immunol 137:1874–1877

    PubMed  CAS  Google Scholar 

  • Fraser-Smith EB, Matthews TR (1981) Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida ablicans. Infect Immun 34:676–683

    PubMed  CAS  Google Scholar 

  • Fraser-Smith EB, Eppstein DA, Larsen MA, Matthews TR (1983) Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection. Infect Immun 39:172–178

    PubMed  CAS  Google Scholar 

  • Geha RS, Helm B, Gould H (1985) Inhibition of the Prausnitz-Kästner reaction by an immunoglobulin E-chain synthesized by E. coli. Nature 315:577–578

    Article  PubMed  CAS  Google Scholar 

  • Gemsa D, Deimann W, Bärlin E, Seitz M, Leser HG (1982) Die Rolle von Prostaglandinen aus Makrophagen bei Regulation and Suppression der Immunantwort. Allergologie 5:142–150

    CAS  Google Scholar 

  • Gifford RRM, Ferguson RM, Voss BV (1981) Cimetidine reduction of tumor formation in mice. Lancet 1:638–639

    Article  PubMed  CAS  Google Scholar 

  • Goldstein D, Laszlo J (1986) Perspectives in cancer research: interferon therapy in cancer: from imagination to interferon. Rev Cancer Res 46:4315–4329

    CAS  Google Scholar 

  • Goldstein G, Schindler J, Sheahan M, Barnes L, Tsai H (1985) Orthoclone OKT3 treatment of acute renal allograft rejection. Transplant Proc 17:129–130

    Google Scholar 

  • Goodman MG (1984) Inductive and differentiative signals delivered by C8-substituted guanine ribonucleosides. Immunol Today 5:319–324

    Article  CAS  Google Scholar 

  • Goodwin JS, Ceuppens J (1983) Regulation of the immune response by prostaglandins. J Clin Immunol 3:295–315

    Article  PubMed  CAS  Google Scholar 

  • Goronzy J, Weyand CM, Fathman CG (1986) Long-term humoral unresponsiveness in vivo induced by treatment with monoclonal antibody against L3T4. J Exp Med 164:911–925

    Article  PubMed  CAS  Google Scholar 

  • Greenberg PD, Kern DE, Cheever MA (1985) Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt I +2_ T cells. Tumor eradication does not require participation of cytotoxic T cells. J Exp Med 161:1122–1134

    Article  PubMed  CAS  Google Scholar 

  • Greenstein JL, Malissen B, Burakoff SJ (1985) Role of L3T4 in antigen-driven activation of a class I-specific T cell hybridoma. J Exp Med 162:369–374

    Article  PubMed  CAS  Google Scholar 

  • Haas W, von Boehmer J (1985) T cell proliferation and differentiation. In: Weissman I (ed) Leukemia. Springer, Berlin Heidelberg New York, pp 21–30

    Chapter  Google Scholar 

  • Hardt C, Röllinghoff M, Pfizenmaier K, Mosmann H, Wagner H (1981) Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin-2 inhibitor in vivo. J Exp Med 154:262–274

    Article  PubMed  CAS  Google Scholar 

  • Hersey P, Bindon C, Bradley M, Hasic E (1984) Effect of isoprinosine on interleukin 1 and 2 production and on suppressor cell activity in poke-weed mitogen stimulated cultures of B and T cells. Int J Immunopharmacol 6:321–328

    Article  PubMed  CAS  Google Scholar 

  • Hess AD, Horwitz L, Beschorner WE, Santos GW (1985) Development of graft versus host disease like syndrome in cyclosporine treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal antiIa specificity including autoreactivity. J Exp Med 161:718–730

    Article  PubMed  CAS  Google Scholar 

  • Hess AD, Colombani PM, Esa AH (1986) Cyclosporine and the immune response: basic aspects. Crit Rev Immunol 6:123–149

    PubMed  CAS  Google Scholar 

  • Hirata F, Schiffmann E, Venkatasubramamian K, Salomon D, Axelrod J (1980) A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci USA 77:2533–2536

    Article  PubMed  CAS  Google Scholar 

  • Hirschhorn R (1983) Metabolic defects and immunodeficiency disorders. N Eng J Med 308:714–716

    Article  CAS  Google Scholar 

  • Honda M, Chan Ch, Shevach EM (1985) Characterization and partial purification of a specific interleukin-2 inhibitor. J Immunol 135:1834–1839

    PubMed  CAS  Google Scholar 

  • Hoyer M, Meinecke T, Lewis W, Zwilling B, Rinehart J (1986) Characterization and modulation of human lymphokine (interleukin-2) activated killer cell induction. Cancer Res 46:2834–2838

    PubMed  CAS  Google Scholar 

  • Isakov N, Scholz W, Altman A (1986) Signal transduction and intracellular events in T lymphocyte activation. Immunol Today 7:271–277

    Article  CAS  Google Scholar 

  • Ishizaka K, Yodoi J, Suemura M, Hirashima M (1983) Isotype specific regulation of the IgE response by IgE binding factors. Immunol Today 4:192–194

    Article  CAS  Google Scholar 

  • Ito M, Bandyopadhyay S, Matsumoto-Kobayashi M, Clark SC, Miller D, Starr SE (1986) Interleukin-2 enhances natural killing of varicella-zoster virus infected targets. Clin Exp Immunol 65:182–189

    PubMed  CAS  Google Scholar 

  • Itoh K, Tilden AB, Kumagai K, Balch ChM (1985) Leu-11 + lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin-2 (rIL-2)-induced activated killer (AK) cells. J Immunol 134:802–807

    PubMed  CAS  Google Scholar 

  • Iwata M, Huff TF, Ishizaka K (1984) Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor determining the nature of IgE-binding factors. J Immunol 132:1286–1293

    PubMed  CAS  Google Scholar 

  • Jansen J, Falkenberg JHF, Stepan DE, LeBien TW (1984) Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies. Semin Hematol 21:164–181

    PubMed  CAS  Google Scholar 

  • Jardieu P, Uede T, Ishizaka K (1984) IgE-binding factor from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor. J Immunol 133:3266–3273

    PubMed  CAS  Google Scholar 

  • Jesdinsky HJ (1983) Cooperative group of additional immunoglobulin therapy in severe bacterial infections: multicenter randomized controlled trial on the efficacy of additional immunoglobulin therapy in cases of diffuse fibrino-purulent peritonitis — study design. Klin Wochenschr 61:445–450

    Article  Google Scholar 

  • Jones PT, Dear PH, Foote J, Neuberger MS, Winter G (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321:522–525

    Article  PubMed  CAS  Google Scholar 

  • Jorizzo JL, Sams MW, Jegasothy BV, Olansky AJ (1980) Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model. Ann Intern Med 92 (1):192–195

    PubMed  CAS  Google Scholar 

  • Katz DH (1984) Regulation of the IgE system: experimental and clinical aspects. Allergy 39:81–106

    Article  PubMed  CAS  Google Scholar 

  • Kawano M, Iwato K, Kuramoto A (1985) Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. J Immunol 134:375–381

    PubMed  CAS  Google Scholar 

  • Kawasaki ES, Ladner MB, Wang AM, et al. (1985) Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 230:291–296

    Article  PubMed  CAS  Google Scholar 

  • Kelley VE, Noar D, Tarcic N, Gaulton GN, Strom TB (1986) Anti-interleukin-2 receptor antibody suppresses delayed-type hypersensitivity to foreign and syngeneic antigens. J Immunol 137:2122–2124

    PubMed  CAS  Google Scholar 

  • Kingston AE, Kay JE, Ivanyi J (1985) The effects of prostaglandin E and I analogues on lymphocyte stimulation. Int J Immunopharmacol 7:57–64

    Article  PubMed  CAS  Google Scholar 

  • Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Ythier A, Strom TB (1985) Administration of anti-interleukin-2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J Exp Med 162:358–362

    Article  PubMed  CAS  Google Scholar 

  • Konrad MW, Bradley EC (1986) The pharmacokinetics of a recombinant IL-2 muteine given by five routes in a number of phase I trials (abstract). Proc Am Soc Clin Oncol 5:235

    Google Scholar 

  • Kramer M, Koszinowski U (1982) T cell-specific suppressor factor(s) with regulatory influence on interleukin-2 production and function. J Immunol 128:784–790

    PubMed  CAS  Google Scholar 

  • Krönke M, Leonard WJ, Depper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, Greene WC (1984) Cyclosporine A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 81:5214–5218

    Article  PubMed  Google Scholar 

  • Kuff EL, Mietz JA, Troustine ML, Moore KW, Martens CL (1986) cDNA clones encoding murine IgE-binding factors represent multiple structural variants of intracisternal A-particle genes. Proc Natl Acad Sci USA 83:6583–6587

    Article  PubMed  CAS  Google Scholar 

  • Kuo LM, Robb RJ (1986) Structure function relationships for the IL-2 receptor system. 1. Localization of a receptor binding site on IL-2. J Immunol 137:1538–1543

    PubMed  CAS  Google Scholar 

  • Kuo LM, Rusk CM, Robb RJ (1986) Structure function relationship for the IL-2 receptor system. II. Localization of an IL-2 binding site on high and low affinity receptors. J Immunol 137:1544–1551

    PubMed  CAS  Google Scholar 

  • Kupiec-Weglinski JW, Diamantstein T, Tilney NL, Strom TB (1986) Therapy with monoclonal antibody to interleukin-2 receptors spares suppressor T cells and prevents or reverses acute allograft rejection in rats. Proc Natl Acad Sci USA 83:2624–2627

    Article  PubMed  CAS  Google Scholar 

  • Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH (1986) The relationship of CD/6 (Leu 11), Leu 19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136:4480–4485

    PubMed  CAS  Google Scholar 

  • Like AA, Biron CA, Weringer EJ, Byman K, Sroczynski E, Guberski DL (1986) Prevention of diabetes in biobreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 164:1145–1159

    Article  PubMed  CAS  Google Scholar 

  • Liu FT, Albrand K, Mendel E, Kulczycki, Orida NK (1985) Identification of an IgE-binding protein by molecular cloning. Proc Natl Acad Sci USA 82:4100–4104

    Article  PubMed  CAS  Google Scholar 

  • Lomedico PT, Gubler U, Hellmann CP, Dukovich M, Giri JG, Pan Y-CE, Collier K, Semionow R, Chua AO, Mizel SB (1984) Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312:458–462

    Article  PubMed  CAS  Google Scholar 

  • Lou CY, Wang EY, Li D, Budz-Tymkewycz S, Visconti V, Ishague A (1985) Mechanism of action of a suppressor-activating factor (SAF) produced by a human T cell line. J Immunol 134:3155–3162

    Google Scholar 

  • MacDonald HR, Glasebrook AL, Bron C, Kelso A, Cerottini JC (1982) Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. Immunol Rev 68:89–115

    Article  PubMed  CAS  Google Scholar 

  • Marceletti JF, Katz DH (1984) FcRe+ lymphocytes and regulation of the IgE antibody system. IV Delineation of target cells and mechanism of action of SFA and EFA in inhibiting in vitro induction of FcRe expression. J Immunol 133:2845–2851

    Google Scholar 

  • Marrack P, Endrew R, Shimonkevitz R, Zlotnik A, Dialynas D, Fitch F, Kappler J (1983) The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J Exp Med 158:1077–1091

    Article  PubMed  CAS  Google Scholar 

  • Medoff JR, Clack VD, Roche JK (1986) Characterization of an immunosuppressive factor from malignant ascites that resembles a factor induced in vitro by carcinoembryonic antigen. J Immunol 137:2057–2064

    PubMed  CAS  Google Scholar 

  • Merluzzi VJ, Last-Barney K (1985) Potential use of human interleukin-2 as an adjunct for the therapy of neoplasia, immunodeficiency and infectious disease. Int J Immunopharmacol 7:31–39

    Article  PubMed  CAS  Google Scholar 

  • Metcalf D (1985) The granulocyte-macrophage colony-stimulating factors. Science 229:16–22

    Article  PubMed  CAS  Google Scholar 

  • Moingeon M, Ythier A, Goubin G, Faure F, Nowill A, Delmon L, Rainaud M, Forestier F, Daffos F, Bohuon C, Hercend T (1986) A unique T cell receptor complex expressed on human fetal lymphocytes displaying natural killer like activity. Nature 323:638–640

    Article  PubMed  CAS  Google Scholar 

  • Morley J (1979) Prostaglandins and chronic inflammation. In: Rainsford KD, Ford-Hutchinson AW (eds) Prostaglandins and inflammation. Birkhäuser, Basel, pp 133–141

    Chapter  Google Scholar 

  • Morley J (ed) (1982) Bronchial hyperreactivity. Academic, London

    Google Scholar 

  • Morrison SL (1985) Transfectomas provide novel chimeric antibodies. Science 229:1202–1207

    Article  PubMed  CAS  Google Scholar 

  • Nakamura T, Miyasaka N, Pope RM, Talal N, Russel IJ (1983) Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases. Clin Exp Immunol 52:67–74

    PubMed  CAS  Google Scholar 

  • Nathan CF, Murray HW, Wiebe ME, Rubin BY (1983) Identification of interferon-y as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158:670–689

    Article  PubMed  CAS  Google Scholar 

  • Neuberger MS, Williams GT, Fox RO (1984) Recombinant antibodies possessing novel effector functions. Nature 312:604–608

    Article  PubMed  CAS  Google Scholar 

  • Nicola NA, Begley CG, Metcalf D (1985) Identification of the human analogue of a regulator that induces differentiation in murine leukemic cells. Nature 314:625–628

    Article  PubMed  CAS  Google Scholar 

  • Nishizuka Y (1984) Turnover of inositol phospholipids and signal transduction. Science 225:1365–1370

    Article  PubMed  CAS  Google Scholar 

  • Nydegger UE (1985) Suppressive and substitutive immunotherapy: an essay with a review of recent literature. Immunol Lett 9:185–190

    Article  PubMed  CAS  Google Scholar 

  • Obert HJ, Brzoska J (1986) Interferon-y in therapy of rheumatoid arthritis. Drug Res 36:1557–1560

    CAS  Google Scholar 

  • Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK (1986) There is more than one interleukin-1 Immunol. Today 7:45–56

    CAS  Google Scholar 

  • Ortaldo JR, Mason A, Overton R (1986) Lymphokine-associated killer cells. Analysis of progenitors and effectors. J Exp Med 164:1193–1205

    Article  PubMed  CAS  Google Scholar 

  • Ortho Multicenter Tranplant Group (1985) A randomized clinical trial OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 313:337–342

    Article  Google Scholar 

  • Oshimi K, Oshimi Y, Akutsu M, Takei Y, Saito H, Okada M, Mizoguchi H (1986) Cytotoxicity of interleukin activated lymphocytes for leukemia and lymphoma. Blood 68:938–948

    PubMed  CAS  Google Scholar 

  • Pasino M, Bellone M, Cornaglia P, Tonini GP, Massimo L (1982) Methisoprinol effect on enriched B and T lymphocyte populations stimulated with phytohemagglutinin. J Immunopharmacol 4:101–108

    Article  PubMed  CAS  Google Scholar 

  • Pestka S (1986) Interferons from 1981–1986. Methods Enzymol 119:3–14

    Article  PubMed  CAS  Google Scholar 

  • Phillips JH, Lanier LL (1986) Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med 164:814–825

    Article  PubMed  CAS  Google Scholar 

  • Pizza G, Severini G, Menniti D, DeVinci C, Corrado F (1984) Tumor regressions after intralesional injection of interleukin-2 (IL-2) in bladder cancer: preliminary report. Int J Cancer 34:359–367

    Article  PubMed  CAS  Google Scholar 

  • Raefsky EL, Gascon P, Gratwohl A, Speck B, Young NS (1986) Biological and immunological characterization of ATG and ALG. Blood 68:712–719

    PubMed  CAS  Google Scholar 

  • Rappaport RS, Dodge GR (1982) Prostaglandin E inhibits the production of human interleukin-2. J Exp Med 155:943–948

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg SA (1984) Adoptive immunotherapy of cancer: accomplishments and prospects. Cancer Treat Rep 68:233–255

    PubMed  CAS  Google Scholar 

  • Rosenberg SA (1985) Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. J Natl Cancer Inst 75:595–603

    PubMed  CAS  Google Scholar 

  • Rosenberg SA, Lotze MT, Muul LM, et al. (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313:1485–1492

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318–1321

    Article  PubMed  CAS  Google Scholar 

  • Rothhut B, Russo-Marie F, Wood J, DiRosa M, Flower RJ (1983) Further characterization of the glucocorticoid-induced antiphospholipase protein “Renocortin”. Biochem Biophys Res Commun 117:878–884

    Article  PubMed  CAS  Google Scholar 

  • Schulte-Wissermann H, Schofer O, Dinkel E (1982) Die Therapie mit y-Globulin. Struktur, Wirkungsweise and Einsatzmöglichkeiten intravenös applizierbarer y-Globulinpräparate. Immun Infekt 10:98–109

    PubMed  CAS  Google Scholar 

  • Sell S, Reisfeld RA (1985) Monoclonal antibodies in cancer. Human Press, Clifton, New Jersey

    Book  Google Scholar 

  • Shirakawa F, Tanaka Y, Oda S, Chiba S, Suzuki H, Eto S, Yamashita U (1986) Immuno-suppressive factors from adult T cell leukemia cells. Cancer Res 46:4458–4462

    PubMed  CAS  Google Scholar 

  • Shu-Mei Liang, Thatcher DR, Chi-Ming Liang, Allet B (1986) Studies of structure-activity relationship of human interleukin-2. J Immunol 261:334–337

    CAS  Google Scholar 

  • Sidiropoulos D, Böhme U, von Muralt G, Morell A, Barandun S (1981) Immunglobulin-substitution bei der Behandlung der neonatalen Sepsis. Schweiz Med Wochenschr 111:1649–1655

    PubMed  CAS  Google Scholar 

  • Sondel MP, Hank JA, Kohler PC, Chen BP, Minkoff DZ, Molenda JA (1986) Destruction of autologous human lymphocytes by interleukin-2 activated cytotoxic cells. J Immunol 137:502–511

    PubMed  CAS  Google Scholar 

  • Souza LM, Boone TC, Gabrilove A, et al. (1986) Recombinant human granulocyte colony- stimulating factor: effects on normal and leukemic myeloid cells. Science 232:61–65

    Article  PubMed  CAS  Google Scholar 

  • Steinman L, Rosenbaum J, Sriram S, McDevitt HO (1981) In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis. Proc Natl Acad Sci USA 78:7111–7114

    Article  PubMed  CAS  Google Scholar 

  • Stevenson GT (1986) The prospect for treating cancer with antibody. Sci Prog 70:505–519

    PubMed  CAS  Google Scholar 

  • Storb R, Deeg HJ, Whitehead J, et al. (1986) Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Eng J Med 314:729–735

    Article  CAS  Google Scholar 

  • Suzuki S, Huchet R (1981) Mechanism of histamine-induced inhibition of lymphocyte response to mitogens in mice. Cell Immunol 62:396–405

    Article  PubMed  CAS  Google Scholar 

  • Swain SL (1983) T cell subsets and the recognition of MHC class. Immunol Rev 74:129–142

    Article  PubMed  CAS  Google Scholar 

  • Talmadge JE, Lenz BF, Klabonsky R, Simon R, Rigg C, Guo S, Oldham RK, Fidler IJ (1986) Therapy of autochthonous skin cancers in mice with intravenously injected liposomes containing muramyltripeptide. Cancer Res 46:1160–1163

    PubMed  CAS  Google Scholar 

  • Tandom P, Utsugi T, Sone S (1986) Lack of production of interleukin-1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide. Cancer Res 46:5039–5044

    Google Scholar 

  • Thurman GB, Maluish AE, Rossio JL et al. (1986) Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations. J Biol Response Mod 5:85–107

    PubMed  CAS  Google Scholar 

  • Traber R, Kuhn M, Rilegger A, Lichti H, Loosli HR, von Wartburg A (1977a) Die Struktur von Cyclosporin C. Helv Chim Acta 60:1247–1255

    Article  CAS  Google Scholar 

  • Traber R, Kuhn M, Loosli HR, Pache W, von Wartburg A (1977b) Neue Cyclopeptide aus Trichoderma polysporum (Link ex Pers.) Rifai: die Cyclosporine B, D and E. Helv Chim Acta 60:1568–1578

    Article  CAS  Google Scholar 

  • Trang LE (1980) Prostaglandins and inflammation. Semin Arthritis Rheum 9:153–159

    Article  PubMed  CAS  Google Scholar 

  • Uede T, Hirata F, Hirashima M, Ishizaka K (1983) Modulation of the biologic activities of IgE-binding factors. I. Identification of glycosylation-inhibiting factor as a fragment of lipomodulin. J Immunol 130:878–884

    PubMed  CAS  Google Scholar 

  • Uede T, Huff TF, Ishizaka K (1984) Suppression of IgE synthesis in mouse plasma cells and B cells by rat IgE-suppressive factor. J Immunol 133:803–808

    PubMed  CAS  Google Scholar 

  • Waldor MK, Sriram S, McDevitt HO, Steinman L (1983) In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor. Proc Natl Acad Sci USA 80:2713–2717

    Article  PubMed  CAS  Google Scholar 

  • Waldor MK, Hardy RR, Hayakawa K, Steinman L, Herzenberg LA, Herzenberg LA (1984) Disappearance and reappearance of B cells after in vivo treatment with monoclonal anti-I-A antibodies. Proc Natl Acad Sci USA 81:2855–2858

    Article  PubMed  CAS  Google Scholar 

  • Waldor MK, Sriram S, Hardy R, Herzenberg LA, Herzenberg LA, Lanier L, Lim M, Steinman L (1985) Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T cell subset marker. Science 227:415–419

    Article  PubMed  CAS  Google Scholar 

  • Walker C, Kristensen F, Bettens F, deWeck AL (1983) Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin-2 production. J Immunol 130:1770–1773

    PubMed  CAS  Google Scholar 

  • Wallner BP, Mattaliano RJ, Hession C, Cate RL, Tizard R, Sinclair LK, Foeller C, Pingchang Chow E, Browning JL, Ramachandran KL, Pepinsky RB (1986) Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 320:77–81

    Article  PubMed  CAS  Google Scholar 

  • Wang A, Shi-Da Lu, Mark DF (1984) Site specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science 224:1431–1433

    Article  PubMed  CAS  Google Scholar 

  • Ward JR, Samuelson CO (1982) Nonsteroidal antiinflammatory drugs. In: Isselbacher KJ (ed) Update II. Harrison’s principles of internal medicine. McGraw Hill, New York, pp 91–110

    Google Scholar 

  • Weigent DA, Hoeprich PD, Bost KL, Brunck TK, Reiher WE, Blalock JE (1986) The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun 139:367–374

    Article  PubMed  CAS  Google Scholar 

  • Whiteside TL, Miescher S, Hürlimann J, Moretta L, von Fliedner V (1986a) Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors. Int J Cancer 37:803–811

    Article  CAS  Google Scholar 

  • Whiteside TL, Miescher S, MacDonald HR, von Fliedner V (1986b) Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients. J Immunol Methods 90:221–233

    Article  CAS  Google Scholar 

  • Wofsy D, Seaman WE (1985) Successful treatment of autoimmunity in NZB/NZW F 1 mice with monoclonal antibody L3T4. J Exp Med 161:378–391

    Article  PubMed  CAS  Google Scholar 

  • Wofsy D, Mayes DC, Woodcook J, Seaman WE (1985) Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice. J Immunol 135:1698–1703

    PubMed  CAS  Google Scholar 

  • Yanagi Y, Caccia N, Kronenberg M, et al. (1985) Gene rearrangement in cells with natural killer activity and expression of the ß-chain of the T cell antigen receptor. Nature 314:631–633

    Article  PubMed  CAS  Google Scholar 

  • Yodoi J, Hirashima M, Ishizaka K (1982) Regulatory role of IgE-binding factors from rat T lymphocytes. V. Carbohydrate moieties in IgE-potentiating factors and IgE-suppressive factor. J Immunol 128:289–295

    PubMed  CAS  Google Scholar 

  • Young LS (1985) Monoclonal antibodies: technology and application to gram-negative infections. Infection 13:224–228

    Article  Google Scholar 

  • Yu-Chung Yang, Ciarletta AB, Temple PA, Chung MP, Kovacic S, Witek-Giannotti JAS, Leary AC, Kriz R, Clark SC (1986) Human IL-3 (multi CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 47:3–10

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Drews
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Haas
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Research Department, CIBA-GEIGY AG, CH-4002, Basel, Switzerland

    Michael A. Bray Ph. D.

  2. Pharmaceutical Division, Preclinical Research, SANDOZ Ltd., CH-4002, Basel, Switzerland

    John Morley Ph. D., FRC Path.

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Drews, J., Haas, W. (1988). Future Prospects for Drug Design of Lymphocyte Modulators. In: Bray, M.A., Morley, J. (eds) The Pharmacology of Lymphocytes. Handbook of Experimental Pharmacology, vol 85. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73217-1_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73217-1_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73219-5

  • Online ISBN: 978-3-642-73217-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation